In multiple myeloma, MALAT1 protects HMGB1 from ubiquitin-mediated degradation, elevating HMGB1 levels to drive autophagy and suppress apoptosis, contributing to resistance to chemotherapeutic agents [147]. Here, HMGB1 is linked to AL amyloidosis.